Procter & Gamble Health (PGHL.NS) Stock Price

Procter & Gamble Health Price

NSE·CLOSED
6,604.50INR+35.50 (+0.54 %)
Market closed

Revenue has compounded at 5.6% per year over the past 19 years to 9.34 B INR. Earnings per share have grown at 3.1% per year over the last 19 years. Procter & Gamble Health's net margin stands at 25.1%, up from 17.5% several years earlier. Procter & Gamble Health currently offers a dividend yield of about 1.89%. The payout ratio is around 89% of earnings. The dividend has grown at 10.7% per year over the past 18 years. Analysts set a median price target of 5,339.70 INR, implying 19.2% below the current price. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus. The stock trades about 38% above its 52-week low.

Procter & Gamble Health stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Procter & Gamble Health over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Procter & Gamble Health stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Procter & Gamble Health's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Procter & Gamble Health Stock Price History
DateProcter & Gamble Health Price
7/31/20266,604.50 INR
7/30/20266,569.00 INR
7/29/20266,615.50 INR
7/28/20266,798.50 INR
7/27/20266,784.00 INR
7/24/20266,714.00 INR
7/23/20266,741.50 INR
7/22/20266,712.00 INR
7/21/20266,779.50 INR
7/20/20266,852.50 INR
7/17/20266,761.00 INR
7/15/20266,867.00 INR
7/14/20266,918.50 INR
7/13/20266,867.00 INR
7/10/20266,839.00 INR
7/9/20266,612.00 INR
7/8/20266,262.50 INR
7/7/20266,404.00 INR
7/3/20266,346.50 INR
7/2/20266,463.00 INR
7/1/20266,344.50 INR
6/30/20266,326.50 INR
6/29/20266,246.50 INR
6/25/20266,232.50 INR
6/24/20266,248.00 INR
6/23/20266,203.50 INR
6/22/20266,305.00 INR
6/19/20266,326.50 INR
6/18/20266,263.00 INR
6/17/20266,211.00 INR
6/16/20266,208.50 INR
6/15/20266,280.00 INR
6/12/20266,236.00 INR
6/11/20266,209.00 INR
6/10/20266,238.00 INR
6/9/20266,212.50 INR
6/8/20266,199.50 INR
6/5/20266,208.50 INR
6/4/20266,201.00 INR
6/3/20266,108.50 INR
6/2/20266,030.50 INR
6/1/20266,047.00 INR
5/29/20266,328.50 INR
5/27/20266,291.00 INR
5/26/20265,677.50 INR
5/25/20265,618.00 INR
5/22/20265,559.50 INR
5/21/20265,372.50 INR
5/20/20265,382.00 INR
5/19/20265,340.50 INR
5/18/20265,255.00 INR
5/15/20265,300.00 INR
5/14/20265,260.50 INR
5/13/20265,220.00 INR
5/12/20265,099.00 INR
5/11/20265,260.00 INR
5/8/20265,355.00 INR
5/7/20265,320.50 INR
5/6/20265,338.50 INR
5/5/20265,173.00 INR
5/4/20265,151.00 INR
4/30/20265,216.90 INR
4/29/20265,135.00 INR
4/28/20265,112.90 INR
4/27/20265,175.50 INR
4/24/20265,138.70 INR
4/23/20265,205.90 INR
4/22/20265,132.90 INR
4/21/20265,084.30 INR
4/20/20265,086.00 INR
4/17/20265,022.90 INR
4/16/20264,997.70 INR
4/15/20264,939.20 INR
4/13/20264,976.10 INR
4/10/20264,943.00 INR
4/9/20264,802.10 INR
4/8/20264,843.60 INR
4/7/20264,821.60 INR
4/6/20264,810.70 INR
4/2/20264,778.60 INR
4/1/20264,801.50 INR
3/30/20264,815.00 INR
3/27/20264,807.00 INR
3/25/20264,933.00 INR
3/24/20264,801.80 INR
3/23/20264,800.00 INR
3/20/20264,859.50 INR
3/19/20264,818.00 INR
3/18/20264,936.00 INR
3/17/20264,918.00 INR
3/16/20264,890.00 INR
3/13/20264,832.00 INR
3/12/20264,898.00 INR
3/11/20264,886.20 INR
3/10/20264,880.00 INR
3/9/20264,841.00 INR
3/6/20264,883.80 INR
3/5/20264,870.00 INR
2/26/20265,083.00 INR
2/25/20265,130.50 INR
2/23/20265,078.00 INR
2/20/20265,020.50 INR
2/19/20265,012.00 INR
2/18/20265,017.50 INR
2/17/20265,090.00 INR
2/16/20265,050.00 INR
2/13/20264,989.00 INR
2/12/20265,179.00 INR
2/11/20265,480.00 INR
2/10/20265,510.00 INR
2/9/20265,380.00 INR
2/6/20265,180.00 INR
2/5/20265,244.00 INR
2/4/20265,250.00 INR
2/3/20265,270.00 INR
2/2/20265,234.50 INR
1/30/20265,303.00 INR
1/29/20265,336.00 INR
1/28/20265,385.00 INR
1/27/20265,400.00 INR
1/23/20265,350.00 INR
1/22/20265,404.50 INR
1/21/20265,390.50 INR
1/20/20265,455.00 INR
1/19/20265,445.00 INR
1/16/20265,450.00 INR
1/14/20265,380.00 INR
1/13/20265,386.00 INR
1/12/20265,427.00 INR
1/9/20265,569.00 INR
1/8/20265,706.00 INR
1/7/20265,700.00 INR
1/6/20265,750.00 INR
1/5/20265,840.00 INR
1/2/20265,714.00 INR
1/1/20265,729.00 INR
12/31/20255,710.00 INR
12/30/20255,689.50 INR
12/29/20255,665.00 INR
12/26/20255,644.50 INR
12/24/20255,620.50 INR
12/23/20255,678.00 INR
12/22/20255,646.00 INR
12/19/20255,700.00 INR
12/18/20255,674.00 INR
12/17/20255,728.00 INR
12/16/20255,693.00 INR
12/15/20255,650.00 INR
12/12/20255,577.50 INR
12/11/20255,656.00 INR
12/10/20255,652.50 INR
12/9/20255,594.00 INR
12/8/20255,639.00 INR
12/5/20255,685.00 INR
12/4/20255,856.00 INR
12/3/20255,795.00 INR
12/2/20255,760.50 INR
12/1/20255,844.00 INR
11/28/20255,722.50 INR
11/27/20255,780.00 INR
11/26/20255,806.00 INR
11/25/20255,830.00 INR
11/24/20255,858.50 INR
11/21/20255,870.50 INR
11/20/20255,906.00 INR
11/19/20255,892.50 INR
11/18/20255,900.00 INR
11/17/20255,920.00 INR
11/14/20255,869.00 INR
11/13/20255,812.50 INR
11/12/20255,888.00 INR
11/11/20255,908.50 INR
11/10/20255,957.50 INR
11/7/20255,860.00 INR
11/6/20255,920.00 INR
11/4/20256,051.00 INR
11/3/20256,065.00 INR
10/31/20256,152.00 INR
10/30/20256,188.50 INR
10/29/20256,183.50 INR
10/28/20256,173.50 INR
10/27/20256,148.00 INR
10/24/20256,100.00 INR
10/23/20256,116.00 INR
10/21/20256,165.50 INR
10/20/20256,130.00 INR
10/17/20256,243.50 INR
10/16/20256,270.00 INR
10/15/20256,166.00 INR
10/14/20256,131.50 INR
10/13/20256,139.00 INR
10/10/20256,199.00 INR
10/9/20256,100.00 INR
10/8/20256,240.00 INR
10/7/20256,234.50 INR
10/6/20256,210.00 INR
10/3/20256,288.00 INR
10/1/20256,296.50 INR
9/30/20256,308.00 INR
9/29/20256,301.50 INR
9/26/20256,288.50 INR
9/25/20256,370.00 INR
9/24/20256,274.50 INR
9/23/20256,296.00 INR
9/22/20256,251.00 INR
9/19/20256,379.00 INR
9/18/20256,265.50 INR
9/17/20256,330.00 INR
9/16/20256,360.00 INR
9/15/20256,271.00 INR
9/12/20256,225.00 INR
9/11/20256,330.50 INR
9/10/20256,329.50 INR
9/9/20256,500.00 INR
9/8/20256,528.00 INR
9/5/20256,465.50 INR
9/4/20256,450.50 INR
9/3/20256,321.00 INR
9/2/20256,300.00 INR
9/1/20256,300.00 INR
8/29/20256,325.50 INR
8/28/20256,298.50 INR
8/26/20256,307.50 INR
8/25/20256,415.50 INR
8/22/20256,581.50 INR
8/21/20256,338.50 INR
8/20/20256,276.00 INR
8/19/20256,293.50 INR
8/18/20256,223.00 INR
8/14/20256,290.00 INR
8/13/20256,184.00 INR
8/12/20256,350.00 INR
8/11/20256,338.50 INR
8/8/20256,349.50 INR
8/7/20256,290.00 INR
8/6/20256,152.50 INR
8/5/20256,179.00 INR
8/4/20256,292.00 INR
Access this data via the Eulerpool API
Get Free API Key

Procter & Gamble Health Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
10.09 B INR
2.17 B INR
1.77 B INR
Jan 1, 2022
11.14 B INR
2.47 B INR
1.93 B INR
Jan 1, 2023
12.30 B INR
3.09 B INR
2.29 B INR
Jan 1, 2024
11.51 B INR
2.82 B INR
2.01 B INR
Jan 1, 2025
9.34 B INR
3.04 B INR
2.34 B INR
Jan 1, 2026 (e)
13.52 B INR
3.52 B INR
3.15 B INR
Jan 1, 2027 (e)
15.60 B INR
4.06 B INR
3.74 B INR
Jan 1, 2028 (e)
17.68 B INR
4.60 B INR
4.26 B INR

Procter & Gamble Health Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 3, 2026, 1:37 AM
 
REVENUEB INR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB INR
EBITB INR
EBIT MARGIN%
NET INCOMEB INR
NET INCOME GROWTH%
DIV.INR
DIV. GROWTH%
SHARESM
20132014201520162017201820192020202120222023202420252026e2027e2028e
7.988.689.4010.307.128.4911.5513.5610.0911.1412.3011.519.3413.5215.6017.68
16.088.748.309.61-30.9119.3336.0117.42-25.6110.4810.34-6.38-18.8644.7115.4313.31
47.2446.8947.9651.6256.3560.6667.0860.5265.8163.1363.6364.5066.0166.0166.0166.01
3.774.074.515.324.015.157.758.216.647.047.827.436.178.9210.3011.67
0.670.460.610.990.751.262.412.902.172.473.092.823.043.524.064.60
8.395.346.529.6510.5714.8620.8621.3721.5422.2025.1124.4632.5726.0426.0426.04
0.560.430.540.790.948.392.052.541.771.932.292.012.343.153.744.26
-28.70-22.7224.0747.5718.71793.18-75.5323.83-30.428.8819.17-12.4216.6734.4718.6513.77
2.508.506.007.5011.0015.0024.0042.0090.0052.50145.00110.00125.00155.00186.00223.20
–240.00-29.4125.0046.6736.3660.0075.00114.29-41.67176.19-24.1413.6424.0020.0020.00
17.0017.0017.0017.0017.0017.0016.6017.0017.0017.0016.6016.6016.6216.6216.6216.62
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Procter & Gamble Health generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Procter & Gamble Health retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Procter & Gamble Health's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Procter & Gamble Health has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Procter & Gamble Health's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Procter & Gamble Health stock margins

The Procter & Gamble Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Procter & Gamble Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Procter & Gamble Health.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
65.81 %
21.54 %
17.53 %
Jan 1, 2022
63.13 %
22.20 %
17.27 %
Jan 1, 2023
63.63 %
25.12 %
18.66 %
Jan 1, 2024
64.50 %
24.46 %
17.46 %
Jan 1, 2025
66.01 %
32.56 %
25.09 %
Jan 1, 2026 (e)
66.01 %
26.05 %
23.32 %
Jan 1, 2027 (e)
66.01 %
26.05 %
23.98 %
Jan 1, 2028 (e)
66.01 %
26.05 %
24.07 %

Procter & Gamble Health Stock Revenue, EBIT, Earnings per Share

The Procter & Gamble Health earnings per share therefore indicates how much revenue Procter & Gamble Health has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
593.35 INR
127.82 INR
104.00 INR
Jan 1, 2022
655.53 INR
145.53 INR
113.24 INR
Jan 1, 2023
740.76 INR
186.06 INR
138.24 INR
Jan 1, 2024
693.56 INR
169.67 INR
121.08 INR
Jan 1, 2025
561.91 INR
182.98 INR
141.00 INR
Jan 1, 2026 (e)
813.06 INR
211.76 INR
189.60 INR
Jan 1, 2027 (e)
938.48 INR
244.43 INR
225.00 INR
Jan 1, 2028 (e)
1,063.47 INR
276.98 INR
256.00 INR

Procter & Gamble Health business model & stock analysis

Procter & Gamble Health Ltd. is a leading company in the health and hygiene products industry. The company was founded in 1837 by William Procter and James Gamble in Cincinnati, Ohio. Since then, the company has undergone incredible development and is now a global corporation with more than 95,000 employees and an annual revenue of nearly $70 billion. The business model of Procter & Gamble Health Ltd. is focused on providing customers with high-quality products at an affordable price. The company operates in various areas, including household products, health products, beauty products, and hygiene products. The different divisions of Procter & Gamble Health Ltd. include the following areas: Household products: Brands like Ariel, Ace, and Lenor are among the most well-known offerings from Procter & Gamble Health. The company is also active in the textile care category and offers various products such as the brand Downy. Health products: The company's health products focus on oral and dental care, as well as pain relief and digestive aids. Brands like Oral-B and Vick are among the most well-known in the portfolio. Beauty products: Procter & Gamble Health offers a wide range of beauty products such as shampoo, conditioner, and hair dye. Herbal Essences, Pantene, and Wella are among the most well-known brands in this area. Hygiene products: The company offers products such as toilet paper, diapers, and cleaning agents. Pampers, Charmin, and Swiffer are among the most well-known brands. Procter & Gamble Health Ltd. has a very extensive product portfolio, which also includes brands like Always, Old Spice, and Gillette. Procter & Gamble Health is an innovative company that continuously offers its customers new and improved products. An example of this is the development of Tide Pods, a novel way to wash laundry that is packaged in a completely soluble shell. In addition to continuous product development, the company also places great importance on sustainability and social responsibility. Procter & Gamble Health actively engages in environmental protection and advocates for the improvement of working conditions and quality of life for people worldwide. In summary, Procter & Gamble Health Ltd. is a successful company that enjoys an excellent reputation due to its innovative strength, extensive product range, and commitment to sustainability and social responsibility.

Procter & Gamble Health SWOT Analysis

Strengths

Procter & Gamble Health Ltd benefits from several key strengths:

  • Strong brand reputation and recognition
  • Wide portfolio of well-established and trusted products
  • Extensive global distribution network
  • Strong financial position and resources for research and development
  • Skilled and experienced workforce

Weaknesses

Despite its strengths, Procter & Gamble Health Ltd also faces certain weaknesses:

  • Dependency on a limited number of product categories
  • Reliance on key retailers for sales distribution
  • Vulnerability to changing consumer preferences and trends
  • High competition in the healthcare industry
  • Complex regulations and compliance requirements

Opportunities

Procter & Gamble Health Ltd can capitalize on the following opportunities:

  • Expanding into emerging markets with growing healthcare needs
  • Developing new innovative products to meet evolving consumer demands
  • Acquiring or partnering with complementary healthcare companies
  • Utilizing digital platforms for efficient marketing and customer engagement
  • Increasing focus on preventive healthcare and wellness trends

Threats

Procter & Gamble Health Ltd should be wary of the following threats:

  • Influence of counterfeit products affecting trust in the brand
  • Stringent regulations and compliance challenges
  • Increasing competition from both established and new market players
  • Economic uncertainties and fluctuating exchange rates
  • Emergence of alternative healthcare solutions

Procter & Gamble Health Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Procter & Gamble Health historical P/E ratio, EBIT multiple, and P/S ratio

Procter & Gamble Health annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Procter & Gamble Health shares outstanding

The number of shares of Procter & Gamble Health was 16.62 M in 2025. This indicates how many shares Procter & Gamble Health is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
17.00 M Stocks
Jan 1, 2022
17.00 M Stocks
Jan 1, 2023
16.60 M Stocks
Jan 1, 2024
16.60 M Stocks
Jan 1, 2025
16.62 M Stocks
Jan 1, 2026 (e)
16.62 M Stocks
Jan 1, 2027 (e)
16.62 M Stocks
Jan 1, 2028 (e)
16.62 M Stocks

Procter & Gamble Health Dividend History

20 years of dividend payments

YearAnnual DividendYoY ChangePayments
2026110.00INRYTD—1×
Feb 12, 2026110.00INR↑ 144.4%1/1
2025125.00INR↑ 13.6%2×
Feb 21, 202580.00INR↑ 33.3%1/2
Aug 22, 202545.00INR↓ 43.8%2/2
2024110.00INR↓ 24.1%2×
2023145.00INR↑ 176.2%3×
202252.50INR↓ 41.7%2×
202190.00INR↑ 114.3%1×
202042.00INR↑ 75.0%1×
201924.00INR↑ 60.0%1×
201815.00INR↑ 36.4%1×
201711.00INR↑ 46.7%1×

Procter & Gamble Health dividend history and estimates

In 2025, Procter & Gamble Health paid a dividend amounting to 125.00 INR. Dividend means that Procter & Gamble Health distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Special dividend
Details
Date
Dividend
Dividend (Estimate)
Special dividend
Jan 1, 2021
90.00 INR
0.00 INR
0.00 INR
Jan 1, 2022
52.50 INR
0.00 INR
0.00 INR
Jan 1, 2023
145.00 INR
0.00 INR
0.00 INR
Jan 1, 2024
110.00 INR
0.00 INR
0.00 INR
Jan 1, 2025
125.00 INR
0.00 INR
90.00 INR
Jan 1, 2026
155.00 INR
0.00 INR
0.00 INR
Jan 1, 2027 (e)
0.00 INR
186.00 INR
0.00 INR
Jan 1, 2028 (e)
0.00 INR
223.20 INR
0.00 INR

Procter & Gamble Health dividend payout ratio

In 2025, Procter & Gamble Health had a payout ratio of 88.65%. The payout ratio indicates the percentage of the company's profits that Procter & Gamble Health distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
86.54 %
Jan 1, 2022
46.37 %
Jan 1, 2023
104.89 %
Jan 1, 2024
90.85 %
Jan 1, 2025
88.65 %
Jan 1, 2026 (e)
81.75 %
Jan 1, 2027 (e)
82.67 %
Jan 1, 2028 (e)
87.19 %

Current Procter & Gamble Health forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
85.71 % (6)
Hold
14.29 % (1)
Sell
0.00 % (0)
12M Price Target
5,339.70
Last Price
6,604.50
Currency
INR
12M Return Potential
-19.15 %
LTM Return
0 %

EESG©

Eulerpool ESG Scorecard© for the Procter & Gamble Health stock

71/100
68
Environment
99
Social
45
Governance
E

Environment

20
Scope 1 - Direct Emissions263
Scope 2 - Indirect emissions from purchased energy4,708
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions4,971
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees26
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Procter & Gamble Health shareholder structure

% Name
1.40932%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
0.95813%
DSP Investment Managers Pvt. Ltd.
DSP Investment Managers Pvt. Ltd.
0.75537%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
0.61375%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.
0.53364%
Aditya Birla Sun Life AMC Limited
Aditya Birla Sun Life AMC Limited
0.20976%
AllianceBernstein L.P.
AllianceBernstein L.P.

Procter & Gamble Health Beneficial Ownership Filings (SEC 13D/G)

Free Float
47.8%
Float Shares
-
Shares Outstanding
-

Procter & Gamble Health Executives and Management Board

ZR

Ms. Zeal Rupani

Compliance Officer, Company Secretary

Compensation1.32 M INR
MT

Mr. Milind Thatte

Managing Director, Executive Director · since 2018

Compensation322,340.00 INR
LC

Mr. Lokesh Chandak

Chief Financial Officer, Executive Director · since 2023

Compensation249,350.00 INR
ST

Mr. Suresh Talwar

(86)

Non-Executive Independent Chairman of the Board · since 1984

Compensation23,250.00 INR
SM

Mr. Subramanian Madhavan

(67)

Non-Executive Independent Director

Compensation22,000.00 INR

Frequently asked questions about Procter & Gamble Health

The business model of Procter & Gamble Health Ltd revolves around manufacturing and selling a wide range of consumer healthcare products. As a subsidiary of Procter & Gamble Company, it focuses on developing and marketing products that help consumers improve their health and well-being. Procter & Gamble Health Ltd aims to offer innovative pharmaceuticals, over-the-counter medications, and personal care products to meet the needs of its customers. By consistently delivering high-quality and reliable products, the company strives to maintain a strong market presence and generate sustainable revenue growth.

All fundamentals and in-depth analysis of Procter & Gamble Health

Our stock analysis for Procter & Gamble Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Procter & Gamble Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Procter & Gamble Health Stock
Procter & Gamble Health Revenue→
Procter & Gamble Health Stock
Procter & Gamble Health Net Income→
Procter & Gamble Health Stock
Procter & Gamble Health P/E→
Procter & Gamble Health Stock
Procter & Gamble Health P/S→
Procter & Gamble Health Stock
Procter & Gamble Health EBIT→
Procter & Gamble Health Stock
Procter & Gamble Health Dividend→
Procter & Gamble Health Stock
Procter & Gamble Health Directors Dealings→
Procter & Gamble Health Stock
Procter & Gamble Health Stocks→
Procter & Gamble Health Stock
Procter & Gamble Health Market capitalization→
Procter & Gamble Health Stock
Procter & Gamble Health Debt→
Procter & Gamble Health Stock
Procter & Gamble Health Liabilities→
Procter & Gamble Health Stock
Procter & Gamble Health Equity→
Procter & Gamble Health Stock
Procter & Gamble Health AAQS→
Procter & Gamble Health Stock
Procter & Gamble Health Employees→
Procter & Gamble Health Stock
Procter & Gamble Health ROE→
Procter & Gamble Health Stock
Procter & Gamble Health ROA→
Procter & Gamble Health Stock
Procter & Gamble Health ROCE→
Procter & Gamble Health Stock
Procter & Gamble Health News→
Procter & Gamble Health Stock
Procter & Gamble Health Analyst Price Targets→

Health Stocks

ProcyonProcessa PharmaceuticalsProdia Widyahusada Tbk PTProcept BioroboticsProfarma Distribuidora de Produtos FarmaceuticosProbiotix HealthProfessional Medical Expertise Company SJSCPro-DexProfile SolutionsPro MedicusProgynyPrivia Health GroupAll Stocks A–Z →